Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Request Free Sample
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.
Speak to Analyst

Biobanking Market Research Report By Product and Service (Equipment, Consumables, Services, Software), By Sample Type (Blood Products, Human Tissues, Nucleic Acids, Cell Lines, Biological Fluids, Human Waste Products), By Application (Regenerative Medicine, Life Science Research, Clinical Research), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032.

ID: MRFR/LS/4511-HCR | 100 Pages | Author: Rahul Gotadki| April 2024

Global Biobanking Market Overview

Biobanking Market Size was valued at USD 69.5 billion in 2022. The Biobanking market industry is projected to grow from USD 72.41 Billion in 2023 to USD 93.3 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.1% during the forecast period (2023 - 2032). Significant investments in the research and development of cutting-edge therapeutics like personalized medicine, regenerative medicine, and genomic cancer studies drive the field. Also, the emergence of COVID-19 has positioned biobanks at the forefront of pandemic control measures, propelling the market's organic revenue growth, thus driving the growth of the Biobanking market. These are just a few of the market drivers that are driving the market.Biobanking Market

Source Secondary Research, Primary Research, MRFR Database and Analyst Review

Biobanking Market Trends

  • Growing awareness about biobanking to propel market growth

The blood that stays in the umbilical cord after a baby is delivered is known as cord blood. It is the source of stem cells that are preserved and processed for clinical research that is the most plentiful. The significant need for cord blood preservation in biobanking is projected to expand market potential. Moreover, introducing cord blood stem cell biobanking is a major market driver. For instance, the largest stem cell biobanking in the world was introduced by Lund University in Sweden in February 2020. The biobank will support a study into the genesis of the most prevalent diseases, including Parkinson's and Alzheimer's. The emergence of stem cell biobanks is also significantly influenced by the rising incidence of chronic diseases worldwide. As a result, the growth of the biobanking market will be driven by an increase in the number of biobanks throughout the forecast period. Thus, this factor is driving the market CAGR.

This market has evolved significantly in recent years. The primary market driver is integrating cutting-edge technology with the biobanking system. The biobanking system is undergoing a revolution thanks to virtual biobanking, which reduces time limitations and makes it easier for researchers to undertake their work. Virtual biobanking has raised the market's worth and sped up market expansion by assisting biobanks in generating larger revenue. Also, several software firms are developing software to make the biobanking system easier to use and adopt a virtual biobanking system. Thus, it is anticipated that this aspect will accelerate Biobanking market revenue ly.

Biobanking Market Segment Insights

Biobanking Products and Services Insights

The Biobanking market segmentation, based on products and services includes, equipment, consumables, services, software. The equipment segment held the majority share in 2022 in the Biobanking market data. It is because the number of new biobanks is growing quickly, and initial equipment installation is expensive. A wide range of equipment is available to support various biobanking procedures, including sample preparation, collection, processing, storage, and shipment.

Among the items are cell separators, freezers, thawing apparatus, barcode readers, alarm and monitoring systems. It is anticipated that the laboratory information management systems (LIMS) segment will become a valuable source of revenue. COVID-19 biobanking, testing, and research heavily rely on LIMS.

Biobanking Sample Type Insights

The Biobanking market segmentation, based on sample type includes blood products, human tissues, nucleic acids, cell lines, biological fluids, human waste products. The human tissue segment dominated the market growth in 2022 and is projected to be the faster-growing segment during the forecast period, 2022-2030. This is due to the abundance of biobanks that can keep tissues, the simplicity of obtaining tissue samples, and the accessibility of cutting-edge technology for storing and retrieving banked tissues. For oncology investigations, the need for diseased tissue samples, such as lymphoma, myeloma, ovarian leukemia, brain, prostate, colorectal carcinoma, breast, and lung tissues, is predicted to increase as disease-specific R&D spending rises, hence contributing in the growth of the Biobanking market.

Biobanking Application Insights

The Biobanking market segmentation, based on application includes regenerative medicine, life science research, and clinical research. The life science research segment held the majority share in 2022 in the Biobanking market data. The expansion of sample distribution to academic institutions and pharmaceutical R&D for clinical applications is credited with the dominance. Scientists are under pressure due to the rising prevalence of complicated diseases and the demand for effective treatments. Moreover, a greater CAGR is projected for the regenerative medicine segment during the forecast period. Moreover, pharmaceutical and research organizations worldwide have partnered to carry out clinical trials of regenerative therapies for various uses.

Figure 1 Biobanking Market, by Applications, 2022 & 2030 (USD Billion)

Biobanking Market

Source Secondary Research, Primary Research, MRFR Database and Analyst Review

Biobanking Regional Insights

By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. North America Biobanking market accounted for USD 31.831 billion in 2022 with a share of around 45.80% and is expected to exhibit a significant CAGR growth during the study period. This is due to the numerous clinical trials that academic institutions and pharmaceutical corporations have conducted. Another reason for North America's geographic location is the growing technological progress in setting up virtual biobanks. New product development, partnerships, partnerships, expansions, mergers, and acquisitions are the main strategies used by the organisations in the market.

Further, the major countries studied in the market report are The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.


Biobanking Market

Source Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe Biobanking market accounts for the second-largest market share. This can be linked to the fact that the Nordic nations, including Sweden, Norway, Denmark, and others, have long-standing biobanks. Almost 40% of Iceland's population has given DNA, which is safely and secretly held in the biobanks, according to a post on Engage, a producer of conferences and summits for the life science and pharmaceutical industries. Such contributions and a rising sample supply are expanding the European biobank market's size. Also, ongoing R&D efforts by European pharmaceutical companies are one of the causes contributing to the region's larger market share. Moreover, UK Biobanking market held the largest market share, and the Germany Biobanking market was the fastest growing market in the region.

Asia Pacific Biobanking Market is expected to grow at the fastest CAGR from 2022 to 2030. It is because academic medical institutes are buying more blood and cell samples for research the Asia Pacific region's biobank market will increase over the forecast period due to rising investments in creating well-structured biobanks. Further, the China Biobanking market held the largest market share, and the India Biobanking market was the fastest-growing market in the region.

Biobanking Key Market Players & Competitive Insights

Major market players are spending a lot of money on R&D to increase their product lines, which will help the Biobanking market grow even more. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, with key market developments such as new product launches, mergers and acquisitions, contractual agreements, increased investments, and collaboration with other organizations. Competitors in the Biobanking industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.

One of the primary business strategies adopted by manufacturers in the  Biobanking industry to benefit clients and expand the market sector is to manufacture locally to reduce operating costs. In recent years, Biobanking industry has provided medicine with some of the most significant benefits. The Biobanking market major player such as Hamilton Company, Greiner Holding AG, Promega Corporation, Merck KGaA, VWR Corporation.

The latest generation of approaches to medication development and commercialization are supported by Precision Medicine Group, a company providing specialist services. In the era of precision medicine, precision offers a cohesive infrastructure to help pharmaceutical and life science businesses as they create new products. ProMedDx and GLAS, two top biospecimen providers, were acquired by Precision for Medicine, a division of Precision Medicine Group, in August 2019. With the support of this acquisition, the business will be able to offer more biospecimen solutions and develop its scientific knowledge and understanding.

Biogen Inc. is a Cambridge, Massachusetts-based American multinational biotechnology firm that specializes in the research, development, and distribution of treatments for treating neurological illnesses to patients worldwide. In April 2020, Biogen, Inc. announced a partnership to create a COVID-19 biobank with Partners HealthCare and the Broad Institute of MIT.

Key Companies in the Biobanking market includes

  • Hamilton Company

  • Greiner Holding AG

  • Promega Corporation

  • Becton, Dickinson, and Company

  • Merck KGaA

  • VWR Corporation

  • Tecan Trading AG

  • Thermo Fisher Scientific Inc.

  • Panasonic Healthcare Holdings Co., Ltd.

  • Qiagen N.V.

  • Brooks Automation Inc.

  • Chart Industries Inc.

Biobanking Industry Developments

March 2021 The U.K. Biobank announced in March 2021 that they had updated their data set with information from a study that assessed various circulatory metabolomics indicators. The trials were conducted by Nightingale Health, a Finnish firm that develops blood biomarker technologies, and involved 120,000 individuals.

February 2020 Hamilton Storage introduced new sample storage tubes and RackWare racks in February 2020 at the SLAS 2020 International Conference and Exposition. Furthermore, market participants are forming strategic alliances with research communities and healthcare institutions to effectively meet the need for the storage and processing of biosamples in the biobanking industry.

May 2019 IBBL reported in May 2019 that its Proficiency Testing program in China had shown favorable results. The results suggest that biobanking and laboratory procedures are becoming more standardized on a  scale.

Biobanking Market Segmentation

Biobanking Product and Service Outlook (USD Billion, 2018-2030)

  • Equipment

  • Consumables

  • Services

  • Software

Biobanking Sample Type Outlook (USD Billion, 2018-2030)

  • Blood Products

  • Human Tissues

  • Nucleic Acids

  • Cell Lines

  • Biological Fluids

  • Human Waste Products

Biobanking Application Outlook (USD Billion, 2018-2030)

  • Regenerative Medicine

  • Life Science Research

  • Clinical Research

Biobanking Regional Outlook (USD Billion, 2018-2030)

  • North America

    • US

    • Canada

  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe

  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Australia

    • Rest of Asia-Pacific

  • Rest of the World

    • Middle East

    • Africa

    • Latin America

Biobanking Report Scope
Report Attribute/Metric Details
Market Size 2022 USD 69.5 billion
Market Size 2023 USD 72.41 billion
Market Size 2032 USD 93.3 billion
Compound Annual Growth Rate (CAGR)  4.1 % (2023-2032)
Base Year 2022
Market Forecast Period 2023-2032
Historical Data 2018 - 2021
Market Forecast Units Value (USD Billion)
Report Coverage Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
Segments Covered Product and Services, Sample Type, Application, and Region
Geographies Covered North America, Europe, Asia Pacific, and Rest of the World
Countries Covered The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
Key Companies Profiled Hamilton Company, Greiner Holding AG, Promega Corporation, Merck KGaA, VWR Corporation
Key Market Opportunities Development of Biobanking in emerging countries
Key Market Dynamics Growing awareness about biobanking

Frequently Asked Questions (FAQ) :

The Biobanking market size was valued at USD 69.5 Billion in 2022.

The market is projected to grow at a CAGR of 4.1% during the forecast period, 2023-2032.

North America had the largest share in the market

The key players in the market are Hamilton Company, Greiner Holding AG, Promega Corporation, Merck KGaA, VWR Corporation.

The equipment solutions category dominated the market in 2022.

The life science research had the largest share in the market.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Request Free Sample
Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.
Ask for Customization